Given that more than 40 ligands have been identified for LRP2 to date [12,16], we hypothesize that multiple tissue-, context- and ligand-dependent cellular signaling pathways would be impacted by downregulation of this receptor in cancer cells. This evidence concerns the gene LRP2 and cancer.